First Trust Small Cap Core AlphaDEX Fund (FYX)
| Assets | $934.05M |
| Expense Ratio | 0.60% |
| PE Ratio | 13.66 |
| Shares Out | 8.20M |
| Dividend (ttm) | $0.97 |
| Dividend Yield | 0.85% |
| Ex-Dividend Date | Sep 25, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 11.69% |
| Volume | 12,024 |
| Open | 114.55 |
| Previous Close | 113.71 |
| Day's Range | 113.53 - 114.55 |
| 52-Week Low | 77.66 |
| 52-Week High | 114.55 |
| Beta | 1.09 |
| Holdings | 527 |
| Inception Date | May 8, 2007 |
About FYX
Fund Home PageThe First Trust Small Cap Core AlphaDEX Fund (FYX) is an exchange-traded fund that is based on the Nasdaq AlphaDEX Small Cap Core index. The fund tracks an index of small-cap stocks selected based on quantitatively driven growth and value factors. FYX was launched on May 8, 2007 and is issued by First Trust.
Top 10 Holdings
4.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX | 0.66% |
| Globalstar, Inc. | GSAT | 0.57% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 0.57% |
| Liberty Energy Inc. | LBRT | 0.49% |
| Liquidia Corporation | LQDA | 0.46% |
| Travere Therapeutics, Inc. | TVTX | 0.45% |
| Kohl's Corporation | KSS | 0.45% |
| Alphatec Holdings, Inc. | ATEC | 0.45% |
| GRAIL, Inc. | GRAL | 0.43% |
| Avadel Pharmaceuticals plc | AVDL | 0.43% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 25, 2025 | $0.2692 | Sep 30, 2025 |
| Jun 26, 2025 | $0.0821 | Jun 30, 2025 |
| Dec 13, 2024 | $0.6219 | Dec 31, 2024 |
| Sep 26, 2024 | $0.516 | Sep 30, 2024 |
| Jun 27, 2024 | $0.373 | Jun 28, 2024 |
| Mar 21, 2024 | $0.1234 | Mar 28, 2024 |
Performance
FYX had a total return of 5.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.27%.
News
FYX: Not Among The Best Small Cap ETFs
The First Trust Small Cap Core AlphaDEX Fund has a strategy mixing growth and value styles in small caps. FYX is well-diversified in 525 stocks, with moderate value characteristics, low yield and impr...
Why Is The IPO Market Struggling? Here's What Active Managers Have To Say
Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...
Owning Small-Cap ETFs Still Looks Attractive Even After A Strong Run
Except for Micro-Cap stocks, Small-Cap stocks have been the best-performing size since last fall. I listed some expert views where they might go from here, not all are positive.
Best And Worst Q1 2021: Small Cap Blend ETFs And Mutual Funds
The Small Cap Blend style ranks tenth in Q1'21. Based on an aggregation of ratings of 56 ETFs and 769 mutual funds in the Small Cap Blend style.
Small-Caps Surge: What Now In 2021?
Positive vaccine news boosted hopes for an economic reopening in 2021, which flipped market signals, and small caps and value stocks rallied strongly in November. The Russell 2000 Index, a gauge of U....